Altanine

Altanine is a pre-clinical stage biotechnology company focused on discovering and developing novel therapies for neurodegenerative disorders. The company was co-founded by Arnon Rosenthal, a pioneer in the field of neuro-immunology and the founder of Alector and Rinat Neuroscience. Altanine's research is centered on identifying key biological pathways involved in diseases such as Alzheimer's and ALS to create disease-modifying treatments. Backed by leading life science investors like The Column Group, the company aims to leverage its founders' extensive experience in drug development to address the high unmet medical need in dementia and related conditions.